Trending
Stocks.org
You are at:»»Top Losers: Whiting USA Trust (NYSE:WHX), LipoScience (NASDAQ:LPDX), ZBB Energy Corporation (NYSEMKT:ZBB), Conatus Pharmaceuticals (NASDAQ:CNAT)

Top Losers: Whiting USA Trust (NYSE:WHX), LipoScience (NASDAQ:LPDX), ZBB Energy Corporation (NYSEMKT:ZBB), Conatus Pharmaceuticals (NASDAQ:CNAT)

631
By on Market

Russian Hill Capital, LP (“Russian Hill”), would like to make investors aware of new language that The Bank of New York Mellon Trust Company (the “Trustee”) has included in the latest annual report for Whiting USA Trust (NYSE:WHX). On last trading day Whiting USA Trust (NYSE:WHX) ended up -35.06% lower to close at $3.50 while trading in the range of $3.30 – $5.26. Its return on assets (ROA) is 109.30% while return on investment (ROI) is 117.30%. Whiting USA Trust (NYSE:WHX) monthly performance is -33.59%.

LipoScience Inc (NASDAQ:LPDX) fell more than 21% to a one-year low of $2.97 just before 2 p.m. on Friday after the diagnostics technology company decreased its first-quarter guidance to less than analysts’ estimates after it ended its contract with Health Diagnostic Laboratory. LipoScience Inc (NASDAQ:LPDX) in last trading activity ended up at $ 3.03 with day range of $2.97 – $3.63. Company weekly performance is -25.00% while its quarterly performance stands at -26.46%. LipoScience Inc (NASDAQ:LPDX) is -72.15% away from its 52 week high.

ZBB Energy Corporation (NYSEMKT:ZBB) announced that it has now completed the company’s previously announced underwritten PO of common- stock at the price to the public of $2.25/share. ZBB Energy Corporation (NYSEMKT:ZBB) belongs to Industrial Goods sector with market capitalization of 32.09 M and has 4.20% insider ownership. In last trading activity company’s stock closed at $1.81 while opening price was $2.17.

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) reported a fourth quarter loss of $0.33 per share after the bell Thursday, compared to the loss of $2.36 last year. The consensus estimate was for a loss of $0.27 per share. On Friday shares of Conatus Pharmaceuticals Inc (NASDAQ:CNAT) opened at $9.29 and closed at $8.42. This year Company’s Earnings per Share (EPS) growth is 92.70 % and next year’s estimated EPS growth is 6.70%. Analysts mean target price for is $16.80.

Get Free Updates and Stock Alerts!



*We only send one email per week
Share.

Related Posts

Get Winning Stock Alerts!

Our track record speaks for itself! Our last 7 alerts have delivered combined gains in excess of 300% and there are no signs of slowing down. Join UltimateStockAlerts.com now before you miss out on our next big runner!

We will never sell or share your information.
Close